The pharmaceutical supply chain has gotten more international. Today, the drug industry prefers to purchase Active Pharmaceutical Ingredients (APIs) from other countries for the purpose of cost reduction, increased sourcing and guaranteed supply.
Global sourcing offers many opportunities, but also compliance challenges arise. The regulatory control of imported pharmaceutical ingredients has been tightened by domestic regulators in the USA, the E.U., Canada, Japan, Australia and other countries. One instance of non-compliance may result in delays, rejection of import, warning letters, product recalls, and/or damage to a company's reputation.
Compliance risk mitigation is no longer a quality function, it is also a priority for procurement teams and regulatory professionals along with pharmaceutical manufacturers.
In this article, you'll learn about the most common compliance issues and what businesses can do to create a more secure and compliant API sourcing strategy.
Imported APIs need to be regulated to the same standards as domestic APIs in regulated pharmaceutical markets. The regulatory agencies not only test the product, they test the entire supply chain that brought the product to them.
If an API that's imported doesn't conform to regulatory standards, the repercussions can be serious:
In today's global marketplace, pharmaceutical supply chains are more dynamic with suppliers located all over the world; the Procurement team has to ensure that all suppliers are quality, regulatory and document compliant at all times.
Compliance will not occur before an audit. It needs to be considered as part of the supplier selection, qualification, procurement and supplier management processes.
The very first step towards avoiding common compliance issues is to identify them.
Good Manufacturing Practice (GMP) is one of the most crucial standards for API manufacturers.
As long as you are an experienced supplier, you can get regulatory observations on:
If the supplier's issues are not resolved and are not addressed by the regulatory authority, pharmaceutical manufacturers may encounter a serious dilemma with their suppliers.
The need for documentation on the quality, safety and traceability of products in regulated markets is very great.
Typical documentation problems are:
Documentation may be incomplete, resulting in a delay in the approval process or problems with compliance when it is looked at during inspection.
Many procurement teams in the world use a number of intermediaries when sourcing APIs from around the world. When it is not possible to trace, businesses may encounter problems when it comes to proving:
The absence of transparency will increase compliance risks and will make investigations more difficult in case of a quality problem.
Data integrity is increasingly gaining importance in regulatory environments.
The documentation can be inaccurate or compromised, records may be missing, or poor documentation practices with electronic records can result in substantial regulatory action.
Even if the product quality is good, the customer may not believe in the supplier's business due to poor data quality.
One of the best strategies for minimizing compliance risks is to qualify suppliers.
Procurement teams shouldn't only focus on price when selecting a supplier – they need to also consider quality, regulatory compliance and reliability.
Quality of the product is always directly related to the manufacturing infrastructure of a supplier.
Here are some factors to keep in mind:
Suppliers need to prove their capacity to consistently supply APIs as per regulatory expectations.
Experience is a good indicator of future performance when it comes to suppliers and their regulatory as well as operational experience.
To be reviewed by procurement teams:
Having a good compliance history is a good indication of a more well-developed quality system.
Good quality systems assist to minimise deviations turning into regulatory issues.
Important elements include:
A strong quality culture can often be used as a method to differentiate between reliable suppliers and high risk suppliers.
Supplier audits provide firsthand insight into manufacturing processes.
Audits help procurement and quality staff to assess:
Audits should continue to be a part of any supplier management plan.
One's adherence to the rules is based on documentation.
Procurement and quality teams need to check a number of important documents before importing APIs.
DMFs contain detailed information related to the manufacturing process, facilities, process controls, and quality systems for the manufacture of APIs.
A clean and maintained DMF ensures successful regulatory submissions and transparency of a supplier.
Good Manufacturing Practice certificates are valid as the manufacturing plant has been visited by the regulatory authorities or third party inspection bodies.
All GMP certifications should be checked for authenticity and validity by procurement teams.
CoAs that provide details about the batch of product along with displaying the compliance of the product quality and specification.
All shipments should include analytical documentation and it should be done well.
There is a clear understanding of responsibilities in quality agreements between supplier and buyer.
These contracts can include:
Good quality agreements minimise misunderstandings and enhance the level of supervision of compliance.
India is a critical link in the worldwide supply chain of medicines and one of the world's big API suppliers.
However, not every API supplier in India is equally knowledgeable when it comes to regulatory issues. Not all suppliers are created equal, and it's important to do your due diligence when selecting your supplier.
What to look for in a trustworthy API provider?
Good suppliers will normally provide:
They are prepared to share pertinent good information and work with the customer audit if necessary.
These are some of the important questions to ask, where your Procurement Teams are not involved.
Prior to making a sourcing agreement, buyers must ask:
The responses frequently indicate the supplier's willingness to be compliant.
The following are standardized red flag rules to avoid:
When suppliers demonstrate:
These warning signs can indicate a greater possibility of compliance.
A Bulk API Sourcing Platform can help reduce compliance risk by making it easier. A bulk API sourcing platform can help reduce compliance risks by simplifying the process.
A lot of traditional supplier discovery methods are dependent on uncoordinated information, word of mouth and manual qualification procedures.
This can cause slashed procurement times and increased risk.
The bulk API sourcing platform provides a more systematic and clear-cut supplier identification and qualification process.
This is because verified supplier profiles enable buyers to assess manufacturers' more efficient.
The procurement team is able to see details about:
This helps to make better decisions in the selection of suppliers.
Having information about suppliers in one place can minimize the qualification process delay.
Pro procurement teams will be able to compare documentation more efficiently, rather than having to get information from multiple suppliers.
The procurement platforms are digital and help the management of RFQs and connect buyers with qualified suppliers.
This improves communication, speeds up the sourcing process and improves sourcing decisions.
The 1-to-1 sourcing model allows procurement departments to evaluate suppliers based on the same criteria.
This improves supplier governance and enables quicker detection of compliance risks during the sourcing process.
Compliance in successful pharmaceutical companies is not considered a regulatory process, rather part of procurement strategy.
The following are examples of the elements of a good sourcing framework:
By capturing the compliance value during procurement, it can provide the supply chain with resiliency and reduce disruptions.
APIs are allowed to be imported to regulated markets, offering pharmaceutical companies greater sourcing flexibility and superior supplier options. The benefits are accompanied, however, with many compliance requirements.
Companies with a focus on supplier qualification, documentation verification, GMP compliance and transparency in the supply chain are more likely to avoid more expensive issues related to regulatory compliance.
Global Sourcing is increasingly becoming more complex and difficult, and procurement teams need tools and processes to support the decision making process. This can help to reduce compliance risks and improve the long term performance of the supply chain through cooperation with qualified API suppliers in India, effective supplier monitoring, and by leveraging a credible bulk API sourcing platform.
Compliance is no longer just a regulatory matter but it also constitutes a competitive advantage to ensure quality of product, continuity of business and access to the market in the pharmaceutical industry.